Testing Underway on Combining Covid Vaccines: Johns Hopkins

The transcript discusses the potential combination of Pfizer and AstraZeneca vaccines to enhance global rollout. It covers preliminary data from trials, particularly in the US, and the UK's strategy of delaying the second AstraZeneca dose. The US approach, as guided by Dr. Fauci, emphasizes maintaining prescribed dosing sequences to combat variants. The transcript also highlights vaccine hesitancy and access issues, especially among healthcare workers in long-term care facilities.

What factors contribute to vaccine hesitancy among healthcare workers?

What is the significance of the efficacy rates mentioned in the discussion?